0001437749-26-010731
SEC filingFY2025 was a challenging year for American Shared Hospital Services, marked by a net loss, procedure volume headwinds, and debt covenant-related liquidity risks.
The company recorded a net loss for FY2025, a reversal from the net income reported in FY2024, driven primarily by lower PBRT and Gamma Knife procedure volumes across both its leasing and direct patient services segments. Management attributes the decline in PBRT volumes to normal, cyclical industry fluctuations, while reduced Gamma Knife volumes stem from planned downtime to upgrade and relocate the company’s Peru facility. These segment losses drove an increase in the 2025 income tax benefit, and the company did not capitalize any incremental costs related to customer contract fulfillment during the year. The company anticipates it will record income tax expense if it returns to profitable operations in future periods.
Amid volume headwinds in other service lines, the company saw growth in LINAC procedure volumes during FY2025. This growth is directly attributable to two key strategic actions: the completion of the RI Acquisition in May 2024, and the launch of patient treatments at the company’s new LINAC facility in Puebla, Mexico. This expanded LINAC footprint partially offset performance pressures in other segments during the year.
The company’s primary liquidity needs continue to be funding capital expenditures and supporting working capital requirements. While operating cash flow improved significantly year-over-year in FY2025, capital expenditures outpaced operating cash generation, resulting in negative free cash flow for the period. A notification from Fifth Third asserting an event of default under the company’s credit agreements has increased near-term liquidity risk, driving a decline in net working capital. While the company has historically secured financing for projects from a range of lenders and expects to access similar sources for future projects, there is no assurance that financing will be available on acceptable terms going forward.